We are live on ! Find out more
DNA icon

Ginkgo Bioworks
DNA

173 hedge funds and large institutions have $437M invested in Ginkgo Bioworks in 2025 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 45 increasing their positions, 39 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

224% more call options, than puts

Call options by funds: $26M | Put options by funds: $8.04M

48% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 21

17% more capital invested

Capital invested by funds: $375M → $437M (+$61.9M)

15% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 39

5% more funds holding

Funds holding: 165 → 173 (+8)

7.85% less ownership

Funds ownership: 71.93% → 64.08% (-7.9%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
173
Holders Change
+8
Holders Change %
+4.85%
% of All Funds
2.27%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
31
Increased
45
Reduced
39
Closed
21
Calls
$26M
Puts
$8.04M
Net Calls
+$18M
Net Calls Change
+$5.51M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$4.4M
2
EAM
Erste Asset Management
Austria
+$2.39M
3
State Street
State Street
Massachusetts
+$2.31M
4
Allianz Asset Management
Allianz Asset Management
Germany
+$2.3M
5
CAU
Caxton Associates (UK)
+$1.55M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$15.9M
2
PGCM
Prescott Group Capital Management
Oklahoma
-$8.73M
3
OM
Opaleye Management
Massachusetts
-$5.63M
4
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$5.56M
5
JF
Jump Financial
Illinois
-$4.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$2.55M -$346K -28,944 -14%
AQR Capital Management
27
AQR Capital Management
Connecticut
$2.2M -$157K -13,095 -8%
GCM
28
Glenview Capital Management
New York
$2.18M – – –
Universal-Beteiligungs- und Servicegesellschaft
29
Universal-Beteiligungs- und Servicegesellschaft
Germany
$2.04M +$479K +40,000 +40%
CAU
30
Caxton Associates (UK)
$1.89M +$1.55M +129,588 New
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.78M +$37.8K +3,156 +3%
SPS
32
Susquehanna Portfolio Strategies
Pennsylvania
$1.59M +$1.3M +108,982 New
ACM
33
AH Capital Management
California
$1.58M – – –
SGDR
34
SPX Gestao de Recursos
Brazil
$1.46M +$1.2M +100,000 New
Balyasny Asset Management
35
Balyasny Asset Management
Illinois
$1.43M +$1.17M +97,918 New
Verition Fund Management
36
Verition Fund Management
Connecticut
$1.41M +$27.1K +2,265 +2%
T. Rowe Price Associates
37
T. Rowe Price Associates
Maryland
$1.36M +$61.2K +5,111 +6%
Jane Street
38
Jane Street
New York
$1.24M +$1.02M +85,019 New
EH
39
Equitable Holdings
New York
$1.2M +$257K +21,465 +35%
American Century Companies
40
American Century Companies
Missouri
$1.17M +$267K +22,273 +38%
Jacobs Levy Equity Management
41
Jacobs Levy Equity Management
New Jersey
$1.03M +$848K +70,867 New
AO
42
Allen Operations
New York
$903K – – –
N
43
Nuveen
North Carolina
$858K +$98.6K +8,241 +16%
Swiss National Bank
44
Swiss National Bank
Switzerland
$852K +$19.1K +1,600 +3%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$845K -$14.9K -1,249 -2%
Barclays
46
Barclays
United Kingdom
$843K -$219K -18,328 -24%
UBS AM
47
UBS AM
Illinois
$841K -$291K -24,323 -30%
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$774K -$30.8K -2,571 -5%
Mariner
49
Mariner
Kansas
$771K +$33.3K +2,781 +6%
MVG
50
Madrona Venture Group
Washington
$619K – – –
1
2
3 4 5

DNA Hedge Fund Activity: Q3 2025 in Review

173 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Ginkgo Bioworks (DNA) for Q3 2025, worth a combined $437M — up 17% from $375M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new DNA positions and 21 closed out — a net gain of 10 holders — while 45 added to existing stakes and 39 trimmed.

The largest buyer was BlackRock, adding an estimated $4.4M. The largest seller was Millennium Management, cutting an estimated $15.9M.

  • 173 institutional investors held Ginkgo Bioworks (DNA) as of Q3 2025, up from 165 in Q2 2025.
  • Funds reported $437M of Ginkgo Bioworks stock for Q3 2025, up 17% quarter-over-quarter.
  • 31 funds opened new Ginkgo Bioworks positions in Q3 2025 and 21 closed out, a net change of +10 holders.
  • The largest Ginkgo Bioworks buyer in Q3 2025 was BlackRock, an estimated $4.4M added.
  • The largest Ginkgo Bioworks seller in Q3 2025 was Millennium Management, an estimated $15.9M sold.

Based on aggregated 13F filings for Q3 2025.